81,107,109 Tanzeum was discontinued by GlaxoSmithKline (GSK) in 2017, primarily due to economic factors
Excess homocysteine impairs endothelial function, promotes oxidative stress, and enhances thrombosis, accelerating the progression of cardiovascular conditions
GLP-1 medications may not be appropriate for patients with certain medical histories, including specific thyroid cancer risks, multiple endocrine neoplasia syndrome type 2, serious allergic reactions to the medication or certain gastrointestinal or pancreatic concerns
Clinical research has shown L-Carnitine supports athletic performance and endurance
Nat Reviews Drug Discovery 2025
Our team of drug injury attorneys and class action lawyers is investigating potential GLP-1 gastroparesis lawsuit cases and settlement claims of individuals who were diagnosed with stomach paralysis or gastroparesis after using Ozempic, Mounjaro, Wegovy, Rybelsus, Trulicity, Zepbound, Saxenda or other GLP-1 agonist medications